Atlas · Symbols · Stocks & Shares · CI
Equity · United States

Cigna Group CI

Cigna Group is a hospital & medical service plans issuer listed as CI on NYSE. This free Atlas page links SEC CIK 1739940, Nasdaq Trader and TradingView NYSE:CI, related symbols and the workstation route before a full report is run.

At a glance

CI public profile

Business

Hospital & medical service plans issuer. Atlas tracks CI through its NYSE listing record, chart route and source links.

Listing

CI trades on NYSE. SEC CIK 1739940. Chart route NYSE:CI.

Browse

Nasdaq Trader is the listing identity source for Cigna Group. Atlas files CI under USA Stocks for browsing. The canonical public URL is /stocks/CI/. The workstation link below opens the fuller research run.

Market Wit preview

Cigna's latest supplied number is not a mood, a multiple or a television squabble about healthcare. It is $68.49B of revenue for the quarter ended 2026-03-31, with $1.65B of net income attributable to the parent and $6.26 of diluted earnings per share. That is the useful thing about a large health-services equity: somewhere behind the market shorthand sit employers, government and nongovernment organisations, unions and associations buying products and services for people who do not experience healthcare as an earnings category. The company also reported $7.04B of cash and cash equivalents, which gives the filing some heft without turning it into a victory lap. In this business, the spreadsheet wears a suit, but the product is still appointments...

Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for CI.

Run full research Go Atlas Pro

Daily answer

What changed for Cigna Group today

Open full report
CI daily contextvalidated public digest15 source rail2026-06-19 02:26 UTC

The strongest current fact on Cigna is still the official quarterly filing: The Cigna Group reported revenues of $68.49B, net income attributable to the parent of $1.65B, operating income of $2.36B and diluted earnings per share of $6.26 for the period ending 2026-03-31, according to the 10-Q filed through Official SEC EDGAR.

The company is not just a ticker wrapped around a healthcare label. The supplied 10-Q says the majority of its products and services are offered through employers and other entities, including governmental and nongovernmental organisations, unions and associations. It also identifies Evernorth Health Services and Cigna Healthcare as segment rails, with intersegment revenues mainly reflecting pharmacy and care services transactions between them.

The balance sheet in the same filing gives the equity story its scale: assets of $153.27B, liabilities of $110.82B, stockholders' equity attributable to the parent of $42.21B, cash and cash equivalents of $7.04B and short-term investments of $812.0M for the period ending 2026-03-31. Operating cash flow was $1.13B, inventory was $5.83B and the reported increase in inventories was $-1.51B. The diluted share count was 264.0M shares.

No chart route is supplied in the evidence, so this file does not invent candles, levels, support or resistance. The source route is a filing route: the 2026-04-30 10-Q, the 2026-04-30 8-K announcing results for the three months ended March 31, 2026, the 2026-05-13 8-K, recent Form 4 filings, a Form 144 and the SEC EDGAR filing index and submissions JSON.

What changed in the supplied news rail is documentary rather than cinematic. SEC EDGAR lists Form 4 events dated 2026-06-16, 2026-06-03, 2026-06-02 and 2026-05-14, plus a Form 144 dated 2026-06-12. Those developments can matter for governance and ownership context, but the supplied rail does not parse transaction amounts, motives or market reaction, so the file stays with the named filings rather than turning them into a personality study.

The May 13 8-K adds the caution that keeps the story from becoming a neat earnings postcard. The supplied evidence says the company uses measures intended to show underlying results of operations and aid analysis of trends in revenue, expenses and shareholders' net income, while warning that associated estimates and impacts on shareholders' net income and total revenues could vary materially. It also flags the risk that margins or premiums may be insufficient to cover the cost of services delivered to customers.

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
CI
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView
Source authority

CI evidence rails

Atlas uses the specific public rails available for CI: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify evidence routes and tools; no partnership, sponsorship or endorsement is implied.

TradingView chart NYSE:CI

Atlas has no approved static OHLC cache attached for CI yet, so the profile renders the verified TradingView chart route directly and keeps the full-chart link as fallback.

Open full TradingView chart ->

Run an Atlas research workflow on CI

FreedomCore Atlas operates research workstation templates for company snapshots, DCF, LBO, KYC, NAV tie-outs, and council-grade equity briefs. Each workflow uses public-source filings and structured prompts.

Open Atlas workstation ->
Atlas Pro

Save CI research and exports

Free Atlas users can run full browser research reports from the workstation. Atlas Pro adds 25 custom runs a day, saved research history, email delivery, PDF/CSV exports, and a 25-symbol watchlist. £12/mo founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

CI FAQ

What is Cigna Group (CI)?Cigna Group is a hospital & medical service plans issuer listed as CI on NYSE. This free Atlas page links SEC CIK 1739940, Nasdaq Trader and TradingView NYSE:CI,...

Cigna Group is a hospital & medical service plans issuer listed as CI on NYSE. This free Atlas page links SEC CIK 1739940, Nasdaq Trader and TradingView NYSE:CI, related symbols and the workstation route before a full report is run.

What does Atlas show for CI?The CI page gives the free Atlas profile for Cigna Group: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is...

The CI page gives the free Atlas profile for Cigna Group: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is NYSE:CI; the stable page route is /stocks/CI/. Visible source links include SEC EDGAR CIK 1739940, Nasdaq Trader and TradingView NYSE:CI. Atlas files CI under USA Stocks for browsing.

How often is the CI page updated?The /stocks/CI/ URL is stable. Atlas updates the free CI page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or...

The /stocks/CI/ URL is stable. Atlas updates the free CI page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or published public answer changes.

Which sources does Atlas use for CI?For CI, Atlas starts with SEC EDGAR CIK 1739940, Nasdaq Trader and TradingView NYSE:CI. The SEC CIK 1739940 route is the issuer filing anchor. Nasdaq Trader confirms...

For CI, Atlas starts with SEC EDGAR CIK 1739940, Nasdaq Trader and TradingView NYSE:CI. The SEC CIK 1739940 route is the issuer filing anchor. Nasdaq Trader confirms the listed-symbol identity used by the public directory. NYSE:CI is the chart route shown on the free page. Full workstation reports may add fresh filings, issuer documents, holdings, news, macro context or model-reviewed notes when available.

Can Atlas run a full research brief on CI?Yes. The workstation can open CI, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open CI, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this CI page investment advice?No. The CI page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a...

No. The CI page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-06-19. Browse FreedomCore Atlas research notes →